Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vitamin E and cardiovascular prevention].

C Léger1

  • 1Directeur de recherche INRA, UMI, Faculté de médecine de Montpellier, France.

Annales De Biologie Clinique
|October 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Design of an artificial phage-display library based on a new scaffold improved for average stability of the randomized proteins.

Scientific reports·2023
Same author

Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.

ESMO open·2021
Same author

Pseudo-population bootstrap methods for imputed survey data.

Biometrika·2019
Same author

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis.

Scientific reports·2018
Same author

Protein Electrochemistry: Questions and Answers.

Advances in biochemical engineering/biotechnology·2016
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles

Vitamin E supplementation shows potential cardiovascular benefits by protecting LDL cholesterol and regulating cell functions. However, conclusive evidence for reducing mortality or primary prevention requires further long-term studies.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Nutritional Science

Background:

  • Vitamin E's antioxidant properties are well-documented, particularly its role in protecting low-density lipoprotein (LDL) from oxidation.
  • Oxidized LDL is a key factor in atherosclerosis, suggesting a link between vitamin E and cardiovascular health.
  • Emerging research highlights vitamin E's cell-regulating functions beyond its antioxidant capacity.

Purpose of the Study:

  • To evaluate the efficacy of vitamin E supplementation in reducing cardiovascular disease (CVD) risk.
  • To explore the mechanisms underlying vitamin E's potential cardioprotective effects, including antioxidant and cell-regulatory actions.
  • To assess the impact of different vitamin E dosages and intake sources (supplementation vs. food) on cardiovascular outcomes.

Main Methods:

Related Experiment Videos

  • Analysis of nutritional supplementation trials and consumption studies.
  • Correlation analysis between vitamin E dosage, LDL content, and LDL antioxidant protection.
  • Review of intervention studies in secondary and primary CVD prevention, examining effects on morbidity and mortality.

Main Results:

  • Strong correlation observed between vitamin E doses (>= 50 mg/day), LDL vitamin E content, and LDL antioxidant protection.
  • Nutritional studies suggest vitamin E supplementation, but not dietary intake, may reduce cardiovascular disease risk.
  • Secondary prevention trials show benefits in cardiovascular morbidity (low and high doses), but not mortality; primary prevention trial showed no effect at 50 mg/day.

Conclusions:

  • Vitamin E's antioxidant and cell-regulating properties plausibly contribute to observed cardiovascular benefits.
  • Current evidence from experimental epidemiology does not provide indisputable proof for vitamin E's efficacy in secondary CVD prevention.
  • Further long-term intervention studies with higher doses in primary prevention are needed to establish consensus on vitamin E's role in cardiovascular health.